Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL-Reference-Cited by-同舟云学术

Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL

Published:2010-10-21 Issue:10 Volume:5 Page:e13552
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Accordi Benedetta,Espina Virginia,Giordan Marco,VanMeter Amy,Milani Gloria,Galla Luisa,Ruzzene Maria,Sciro Manuela,Trentin Luca,De Maria Ruggero,Kronnie Geertruy te,Petricoin Emanuel,Liotta Lance,Basso Giuseppe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL).;A Redaelli;Eur J Cancer Care (Engl),2005

2. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.;S Jones;Science,2008

3. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.;Nature,2008

4. Protein microarrays: meeting analytical challenges for clinical applications.;LA Liotta;Cancer Cell,2003

5. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.;EF Petricoin 3rd;J Clin Oncol,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies;Journal of Clinical Investigation;2023-11-15

2. Beyond Corticoresistance, A Paradoxical Corticosensitivity Induced by Corticosteroid Therapy in Pediatric Acute Lymphoblastic Leukemias;Cancers;2023-05-18

3. Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratification;Discover Oncology;2022-12-30

4. The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia;Journal of Proteomics;2021-02

5. New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights;Journal of Enzyme Inhibition and Medicinal Chemistry;2021-01-01